Stay updated on Radiation+Chemo+Ipilimumab+Nivolumab in Stage III NSCLC Clinical Trial
Sign up to get notified when there's something new on the Radiation+Chemo+Ipilimumab+Nivolumab in Stage III NSCLC Clinical Trial page.

Latest updates to the Radiation+Chemo+Ipilimumab+Nivolumab in Stage III NSCLC Clinical Trial page
- Check7 days agoChange DetectedThe page revision has been updated from v3.6.5 to v3.6.6, reflecting a new version of the clinical trial record. It indicates an internal update to the page rather than a substantive change to study details.SummaryDifference0.1%

- Check14 days agoChange DetectedBranding elements referencing the Moffitt Cancer Center Clinical Trials Website and the sponsor, H. Lee Moffitt Cancer Center and Research Institute, have been added to the page. A 'Helpful Links Provided by' label also appears in the related section.SummaryDifference0.2%

- Check21 days agoNo Change Detected
- Check28 days agoChange Detected- Revision label updated from v3.6.4 to v3.6.5 on the page, indicating a new version of the page content.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision: v3.6.4 is now shown on the page, replacing Revision: v3.6.3, indicating an updated version of the page. This change appears to be a metadata/version update rather than a substantive alteration to study data or content.SummaryDifference0.1%

- Check64 days agoChange DetectedThe page’s revision label was updated from v3.6.2 to v3.6.3. This reflects a minor refresh of the page template or content rendering.SummaryDifference0.1%

- Check71 days agoChange DetectedThe page's revision tag was updated from v3.6.0 to v3.6.2, indicating a newer build of the page. This change updates the page version without altering the displayed study details.SummaryDifference0.1%

Stay in the know with updates to Radiation+Chemo+Ipilimumab+Nivolumab in Stage III NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Radiation+Chemo+Ipilimumab+Nivolumab in Stage III NSCLC Clinical Trial page.